RNAZ

TransCode Therapeutics Inc

Jun 12 • 04:00PM ET

5.33

-0.36 -6.33 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: LNAI APRE BCDA BIVI CALC CVM GOVX KAPA KPRX NEUP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-48.65	Insider Own	8.76%	Shs Outstand	0.92M	Perf Week	-4.82%
Market Cap	5.07M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.87M	Perf Month	-23.53%
Enterprise Value	135.50M	PEG	-	EPS next Q	-	Inst Own	3.25%	Short Float	3.23%	Perf Quarter	-45.53%
Income	-43.70M	P/S	-	EPS this Y	-	Inst Trans	2.53%	Short Ratio	0.55	Perf Half Y	-38.24%
Sales	0.00M	P/B	3.91	EPS next Y	-	ROA	-47.38%	Short Interest	0.03M	Perf YTD	-21.96%
Book/sh	1.36	P/C	0.39	EPS next 5Y	-	ROE	-52.14%	52W High	20.99 -74.61%	Perf Year	-26.02%
Cash/sh	13.50	P/FCF	-	EPS past 3/5Y	96.25% 79.17%	ROIC	-27.93%	52W Low	3.82 39.53%	Perf 3Y	-99.99%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	14.30% 14.03%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	95.40%	Oper. Margin	-	ATR (14)	0.72	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.11	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	40.26	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.11	EPS Q/Q	69.67%	SMA20	-4.93%	Beta	1.22	Target Price	280.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-25.58%	Rel Volume	0.11	Prev Close	5.69
Employees	12	LT Debt/Eq	0.00	Earnings	-	SMA200	-42.39%	Avg Volume	50.77K	Price	5.33
IPO	Jul 09, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	67.35% -100.00%	Trades		Volume	5,812	Change	-6.33%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)